ArticleESMO open2026

Lurbinectedin plus irinotecan in pretreated gastroenteropancreatic neuroendocrine neoplasms: results of a phase II expansion cohort.

R Garcia-Carbonero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.